EVP R&D, Chief Medical Officer
Mon, Dec 9, 2024
Dec 9
12,452 shares @ $20.03
Increased holdings by +20.80%
34th largest trade (out of 152)
Cluster Buy
Trade made by an officer
Part of a cluster of 3 transactions by 2 insiders
10b5-1 scheduled trade
0% win rate · -16.3% median edge vs SPY (8 trades, 90-day · small sample)
Insider trade was 36% below market price
Price 18% above 200-day moving average